Tron, Adriana E.
Belmonte, Matthew A.
Adam, Ammar
Aquila, Brian M.
Boise, Lawrence H.
Chiarparin, Elisabetta
Cidado, Justin
Embrey, Kevin J.
Gangl, Eric
Gibbons, Francis D.
Gregory, Gareth P. http://orcid.org/0000-0002-4170-0682
Hargreaves, David
Hendricks, J. Adam
Johannes, Jeffrey W. http://orcid.org/0000-0001-7242-6682
Johnstone, Ricky W.
Kazmirski, Steven L.
Kettle, Jason G.
Lamb, Michelle L. http://orcid.org/0000-0002-3005-8065
Matulis, Shannon M.
Nooka, Ajay K.
Packer, Martin J.
Peng, Bo
Rawlins, Philip B.
Robbins, Daniel W.
Schuller, Alwin G.
Su, Nancy
Yang, Wenzhan http://orcid.org/0000-0002-4591-5007
Ye, Qing
Zheng, Xiaolan
Secrist, J. Paul
Clark, Edwin A.
Wilson, David M.
Fawell, Stephen E.
Hird, Alexander W. http://orcid.org/0000-0002-2699-7449
Article History
Received: 15 May 2018
Accepted: 9 November 2018
First Online: 17 December 2018
Competing interests
: A.E.T., M.A.B., A.A., B.M.A., E.C., J.C., K.J.E., E.G., F.D.G., D.H., J.A.H., J.W.J, S.L.K., J.G.K., M.L.L., M.J.P., B.P., P.B.R., D.W.R., A.G.S., N.S., W.Y., Q.Y., X.Z., J.P.S., E.A.C., D.M.W., S.E.F., and A.W.H. are or were employees of AstraZeneca at the time of conducting these studies. A.K.N. is a consultant/advisory board member for Amgen, GSK, BMS, Janssen, Celgene, Takeda, Adaptive and Spectrum Pharmaceuticals. L.H.B. received honoraria from AstraZeneca and is a consultant for Abbvie and AstraZeneca. R.W.J. receives research support from Abbvie, AstraZeneca, BMS, Roche and MecRX. G.P.G. receives honoraria from Roche and Gilead. S.M.M. declares no competing interests.